Status:
UNKNOWN
Immuno 1: Immune Reconstitution Following Conventional or High-Dose Chemotherapy With Stem Cell Transplant
Lead Sponsor:
Julius-Maximilians University
Collaborating Sponsors:
University of Wuerzburg
Conditions:
Leukemia
Medulloblastoma
Eligibility:
All Genders
Brief Summary
The purpose of this study is to conduct an analysis of the influences of 1. conventional chemotherapy 2. high-dose chemotherapy followed by autologous stem cell transplant 3. high-dose chemotherapy f...
Detailed Description
Detailed analysis will be performed at preselected time points following therapy by * standard flow cytometry in combination with intracellular cytokine/antigen staining * spectratype analysis * TREC...
Eligibility Criteria
Inclusion
- Acute leukemia treated according to current ALL-BFM 2002 protocol
- Solid tumor treated according to current GPOH-protocol
- Medulloblastoma treated according to HIT-2000 protocol
- High-dose chemotherapy followed by autologous stem cell transplantation
- High-dose chemotherapy followed by allogeneic stem cell transplantation
- Written consent according to our institutional guidelines
Exclusion
- No written consent
Key Trial Info
Start Date :
March 1 2005
Trial Type :
OBSERVATIONAL
End Date :
February 1 2009
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00231712
Start Date
March 1 2005
End Date
February 1 2009
Last Update
August 23 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Children's Hospital Pedaitric Oncology
Würzburg, Germany, D97080